31 – 40 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Treatment of invasive streptococcal infection with a peptide derived from human high molecular weight kininogen.
(
- Contribution to journal › Article
-
Mark
Activation of TAFI on the Surface of Streptococcus pyogenes Evokes Inflammatory Reactions by Modulating the Kallikrein/Kinin System
(
- Contribution to journal › Article
-
Mark
SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.
(
- Contribution to journal › Article
-
Mark
C1q inhibits immune complex induced IFN-alpha production in plasmacytoid dendritic cells-A novel link between C1q deficiency and SLE pathogenesis
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2857-2857(
- Contribution to journal › Published meeting abstract
-
Mark
A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
(
- Contribution to journal › Article
- 2008
-
Mark
Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
(
- Contribution to journal › Article
-
Mark
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes.
(
- Contribution to journal › Article
-
Mark
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
(
- Contribution to journal › Article
- 2007
-
Mark
The CXC Chemokine MIG/CXCL9 Is Important in Innate Immunity against Streptococcus pyogenes.
(
- Contribution to journal › Article